Van Weissenbruch, RannyKlimek, LudgerGalffy, GabriellaEmmeluth, MelanieKoltun, ArkadyKopietz, FerdinandNguyen, Duc TungKuhl, Hans ChristianPohl, WolfgangScadding, Glenis KPrice, DavidMullol, Joaquim2020-12-032020-12-032020-12-02Van Weissenbruch, R, Klimek, L, Galffy, G, Emmeluth, M, Koltun, A, Kopietz, F, Nguyen, D T, Kuhl, H C, Pohl, W, Scadding, G K, Price, D & Mullol, J 2020, 'MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis', Journal of Asthma and Allergy, vol. 13, pp. 633—645. https://doi.org/10.2147/JAA.S2777341178-6965https://hdl.handle.net/2164/15445Acknowledgments: We would like to thank the subjects who participated in the trial. The abstract of this paper was presented at the EAACI Congress 2020 as an oral presentation. The presentation’s abstract was published in Allergy: Van Weissenbruch R, Klimek L, Galffy G, et al. MP-Azeflu improves quality of life of patients with allergic rhinitis: a real-world study Funding: Technical, editorial, and medical writing assistance were provided under the direction of the authors by Erin Burns, PhD, and Strategix, an affiliate of The Lynx Group, LLC. Funding for this support was provided by Mylan Inc.133579774engazelastine hydrochloridedaily activitiesfluticasone propionatesleepR MedicineRJournal article10.2147/JAA.S27773413